Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

The updated guidelines noted New Yorkers ages 60 to 74 who are at increased risk of severe RSV ‒ meaning they have certain chronic medical conditions, such as lung or heart disease, or they live ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

In older adults, GSK's Arexvy and Pfizer's Abrysvo offer similar protection against RSV-associated "lower respiratory tract disease" (LRTD), meaning infections that affect the lungs. In the first ...

Geometric mean fold rise in titers from before to 1 month postvaccination for RSV-A and RSV-B were 11.6 vs 1.1 and 12.7 vs 1.1 in the RSVpreF vs placebo group, respectively. Overall, 1.4% and 1.0% ...

The RSV vaccine is not currently an annual vaccine, meaning people do not need to get a dose every RSV season. Eligible adults can get an RSV vaccine at any time, but the best time to get ...

I mean, my initial thought was ... illnesses pop up in the same child at the same time – especially RSV, COVID, and the flu. Typically, it's "just very bad luck," he explained, but sometimes ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, ...